Tarsus Pharmaceuticals, Inc. (TARS) insider trading

By person

14 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Bobak R. Azamian

President/CEO and Board Chair

—

1,709,403

$136.77M

−2.7%

William J Phd Link

Director

—

94,487

$7.56M

−46.8%

Seshadri Neervannan

Chief Operating Officer

—

79,482

$6.36M

+18.2%

Bryan Wahl

General Counsel

—

63,959

$5.12M

+50.0%

Aziz Mottiwala

Chief Commercial Officer

—

61,480

$4.92M

+11.5%

Jeffrey S Farrow

See Remarks

—

56,801

$4.54M

+213.2%

Dianne C. Whitfield

Chief Human Resources Officer

—

35,028

$2.80M

+2.5%

Andrew D. Goldberg

Director

—

19,654

$1.57M

+209.5%

Wendy L Yarno

Director

—

16,956

$1.36M

+63.8%

Elizabeth Yeu Lin

Chief Medical Officer

—

16,177

$1.29M

−51.4%

Bhaskar Chaudhuri

Director

—

11,654

$932.44K

+117.8%

David E I Pyott

Director

—

10,958

$876.75K

+16.9%

Scott W Morrison

Director

—

7,638

$611.12K

—

Katherine Goodrich

Director

—

2,233

$178.66K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Tarsus Pharmaceuticals, Inc.

What the insiders did No buying or selling

By person